Patents by Inventor Lance B. Price

Lance B. Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11406671
    Abstract: Embodiments of the invention provide a method of reducing colonization of a subject's anterior nares and/or nasal cavity by a microorganism (e.g., Staphylococcus aureus). In some aspects, the method may include administering a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a therapeutically effective amount of at least one probiotic.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: August 9, 2022
    Assignee: The Translational Genomics Research Institute
    Inventors: Cindy Liu, Lance B. Price
  • Patent number: 10612053
    Abstract: Methods for the production of lipids and biofuels with a culture of Candidatus Microthrix spp. grown on a medium such as wastewater or sewage sludge are provided. The Candidatus Microthrix spp. may be cultured with additional microorganisms that contribute to the accumulation of lipids from the growth medium such as Zoog!oea spp., Rhizobacter spp., Blautia spp., Hydrolatea spp., ODI genera incertae sedis. Further discloses are transformed organisms comprising genes isolated from Candidatus Microthrix parvicella, as well as methods and processes for producing lipids, fatty acids, or biofuels in vitro using the protein products of the isolated genes.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: April 7, 2020
    Assignees: The Translational Genomics Research Institute, Arizona Board of Regents on behalf of Northern Arizona University, Universite du Luxembourg
    Inventors: Emilie Muller, Paul Wilmes, Paul S. Keim, John D. Gillece, James M. Schupp, Lance B. Price, David M. Engelthaler
  • Publication number: 20180185420
    Abstract: Embodiments of the invention provide a method of reducing colonization of a subject's anterior nares and/or nasal cavity by a microorganism (e.g., Staphylococcus aureus). In some aspects, the method may include administering a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a therapeutically effective amount of at least one probiotic.
    Type: Application
    Filed: April 25, 2016
    Publication date: July 5, 2018
    Inventors: Cindy Liu, Lance B. Price
  • Patent number: 9834823
    Abstract: Disclosed are primers, probes, and single nucleotide polymorphisms (SNP) specific to a distinct subclones of the E. coli sequence type 131 (ST131). Also disclosed are methods and assay kits useful in detecting the presence of the distinct subtype of E. coli and methods of treating a subject suffering from an infection from a subclone of ST131.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: December 5, 2017
    Inventors: Lance B. Price, Evgeni V. Sokurenko, James R. Johnson
  • Publication number: 20150232896
    Abstract: Methods for the production of lipids and biofuels with a culture of Candidatus Microthrix spp. grown on a medium such as wastewater or sewage sludge are provided. The Candidatus Microthrix spp. may be cultured with additional microorganisms that contribute to the accumulation of lipids from the growth medium such as Zoog!oea spp., Rhizobacter spp., Blautia spp., Hydrolatea spp., ODI genera incertae sedis. Further discloses are transformed organisms comprising genes isolated from Candidatus Microthrix parvicella, as well as methods and processes for producing lipids, fatty acids, or biofuels in vitro using the protein products of the isolated genes.
    Type: Application
    Filed: September 18, 2013
    Publication date: August 20, 2015
    Applicant: The Translational Genomics Research Institute
    Inventors: Emilie Muller, Paul Wilmes, Paul S. Keim, John D. Gillece, James M. Schupp, Lance B. Price, David M. Engelthaler
  • Publication number: 20150126435
    Abstract: Disclosed are primers, probes, and single nucleotide polymorphisms (SNP) specific to a distinct subclones of the E. coli sequence type 131 (ST131). Also disclosed are methods and assay kits useful in detecting the presence of the distinct subtype of E. coli and methods of treating a subject suffering from an infection from a subclone of ST131.
    Type: Application
    Filed: July 2, 2013
    Publication date: May 7, 2015
    Inventors: Lance B. Price, Evgueni V. Sokurenko, James R. Johnson
  • Publication number: 20100136523
    Abstract: The preferred therapeutic for human anthrax infections are therapeutics from the fluoroquinolone class, in particular, Ciprofloxacin (CIP). This invention discloses the molecular basis for fluoroquinolone (CEP in particular) action and provides the molecular signatures which form the basis of diagnostic assays. This invention further discloses nucleotide signatures associated with CIP-resistance are useful in diagnostic tests to rapidly identify CIP resistant B. anthracis and to infer the level of resistance of these mutant strains. According to this invention, the diagnostic potential of the molecular signatures is illustrated using a primer extension assay. Further, PCR and extension primers which allow the detection of these signatures are disclosed.
    Type: Application
    Filed: October 14, 2003
    Publication date: June 3, 2010
    Inventors: Paul S. Keim, Talima Pearson, Lance B. Price, Joseph D. Bush